Scottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: The Golden Jubliee National Hospital, Fourth Floor East, Agmemmon St, Clydebank, G81 4DY
News & Events
Stay up to date with latest activity at SHIL
The NHS Clinical Entrepreneurs Series will harness entrepreneurial talent across NHS Scotland to equip health professionals with the skills, knowledge and support to translate innovative ideas into commercial success.
Clinical Entrepreneurs Series - Edinburgh - Thursday 31 January - Programme
Speakers and profiles
Graham Watson, Executive Chairman, Scottish Health Innovations Ltd. (SHIL)
Graham Watson LLB CA FRSA is an experienced non-executive director with a strong commercial track record. He has a rich mix of recent non-executive and advisory responsibilities in Scotland, covering The Law Society of Scotland (where he is a member of Council), the Court of Heriot-Watt University (where he also chairs the Finance Committee), Scottish Futures Trust and North Lanarkshire Leisure Limited (where he also chaired the Audit Committee). He is a former partner in a Big 4 accounting firm, with extensive experience of working with SME clients delivering business development and strategic planning programmes and leading change initiatives. During his career, he has initiated and executed over 100 corporate transactions, valued at over £2bn. He has lived and worked in Silicon Valley, as well as in Scotland, during his 35-year business career.
Dr Robert Rea, Head of Innovation, Scottish Health Innovations Ltd. (SHIL)
Robert Rea holds a BSc (Hons) Developmental Biology, University of Edinburgh, (1998). He completed a PhD in Biology from the University of York in 2002, specifically in genetics of plant cell division, and completed post-doctoral research fellowships at Walter & Eliza Hall Institute, Melbourne, Australia in dendritic cell immunology, 2003-2004. After that, Robert worked at the University of Queensland, Brisbane, Australia developing novel stem cell-based therapies for kidney disease between 2004-2006. Robert became Automation Manager for Swedish biotech company Cellartis in 2007 and became Intellectual Property Manager for French biotech company Cellectis in 2010. He held the position of Business Development Executive at the University of St Andrews from 2013-2014, before joining SHIL as Head of Innovation in 2014.
Prof George Coroner, Honorary Professor of Bioengineering, University of Dundee and Retired Consultant Medical Physicist
Professor George Corner retired from the NHS in 2014 after 36 years’ service, latterly as Consultant Medical Physicist, Head of Instrumentation, NHS Tayside where he was also a collaborator in the establishment of the Dundee ultrasound team. He holds an Honorary Chair in Bio-engineering at Dundee, is a visiting professor to Strathclyde. With these roles, he is able to continue his research interests in the application of Medical Ultrasound both for imaging and therapy. These include Quality Assurance, clinical applications (the development of both devices and applications), Regulation and teaching. Sono-elastography, interventional guidance and HIFU have been areas of particular interest as the focus has always been on the technology clinical interface and translation into practice.
Barbara Blaney, Senior Incubation Manager, MediCityScotland
Following a brief spell as a post-doctoral researcher, Barbara started her industrial career with Johnson & Johnson, followed by clinical project management in Boehringer Mannhein. She has held senior roles in business development in the public and private sector, and was the Scottish Director of the BioIndustry Association. Barbara joined MedCity Scotland from BASF Pharma (Callanish) Ltd, where she was Financial Controller and Communications Manager.
Fiona Mason, Leader of Business Engagement, Edinburgh Napier University
Fiona specialises in the commercialisation of IP and technology and in University- business engagement. She is skilled in IP management, in relationship building and in supporting the translation of academic research into tangible commercial opportunities. Fiona has over 12 years’ experience in working with industry and has significant experience in developing key strategic business relationship accounts, the exploitation of research and innovation and in stakeholder development with external partners (industry, key funding bodies, Research Councils and Innovation Centres).
Phil Harris, CEO, Clear Surgical
Phil has worked in a wide variety of manufacturing organisations for over 30 years, with the last 13 as Managing Director. During his career, he has worked in every business function at all levels providing a unique insight into the complexities of manufacturing organisations. Since 1980 he has been leading strategic change at board level and has led transformation projects around the world. He now has significant experience with company acquisitions and exits having led an MBO of a £26m company in 2004, further UK acquisition and merger, sale of three manufacturing companies in Australia, Switzerland and UK, and 5 selling companies around the world.
Graeme Tydeman, Consultant in Obstetrics and Gynaecology, NHS Fife
In addition to his role as a consultant in Obstetrics and Gynaecology in NHS Fife, Dr Tydeman is a prolific innovator. Alongside experts from Guy’s and St Thomas NHS Foundation Trust, he invented the Desperate Debra, an emergency caesarean simulator which allows medical staff to prepare for life-threatening situations. He also created the blood clock, an art installation which aims to raise awareness of the worldwide problem of severe haemorrhage after childbirth.
Venue and directions
The Clinical Entrepreneurs Series - Edinburgh workshop will take place at:
Surgeons Quarter is a part of The Royal College of Surgeons of Edinburgh, an internationally respected institution and a thriving global network of 25,000 medical professionals, pioneering the advancement of surgical breakthrough and patient care since 1505.